DOI: 10.4244/EIJV14I5A88

Reducing radiation exposure during PCI of chronic total occlusions – better is not good enough

Gerald S. Werner*, MD

The technical advances in percutaneous coronary intervention (PCI) of chronic total occlusions (CTO) are well documented: in randomised trials the success rate has been reported as 87%1,2, and in expert centres above 90%. One aspect of CTO PCI is often neglected in daily practice as it does not carry immediately obvious risks for the patient, namely the radiation exposure during often lengthy procedures. In a meta-analysis of complications related to CTO PCI, radiation risk is mentioned but the incidence was almost zero3. This is too low, because none of the studies reviewed looked for actual damage. Radiation damage to the skin typically appears a few days after discharge on the back of the patient. Even then, it is seldom realised without specific instructions for follow-up examinations. There are a few studies which have explicitly looked for skin injury, revealing a higher incidence when re-examining the patient carefully after the procedure4. Damage to the skin may occur with a skin entry dose as low as 2 Gy and invariably after 5 Gy, leading to different degrees of skin alteration5 (Figure 1).

Figure 1. Example of excessive radiation exposure and skin damage, and minimised radiation exposure in the same patient. A 53-year-old patient underwent PCI for a proximal left anterior descending artery (LAD) CTO (panel A, arrow). In this procedure the operator attempted a retrograde recanalisation via a conus branch from the right coronary artery, which ultimately failed as he could not pass the retrograde wire through the lesion (panel B, arrow). The procedure was documented on 125 cine runs at a rate of 25 cineframes/s in predominantly anteroposterior cranial projection. The estimated radiation dose must have exceeded 15 Gy. C) The patient’s back three months later showed a rectangular patch of discoloured skin with a central ulcerated part. D) A reattempt of the lesion (arrow) was performed in the author’s institution, avoiding the damaged skin area in RAO cranial and plain RAO projections. E) It was a complex retrograde reverse CART procedure (arrow) using an epicardial collateral from the first diagonal to the LAD. F) The procedure was successful with placement of two drug-eluting stents (arrows). The fluoroscopy time was 85 min, with only 2.215 Gy using a low-dose radiation protocol9.

Raising awareness of radiation damage together with a discipline of radiation-saving protocols in the cath lab is important and overdue. Not only has the recanalisation technique evolved, but also X-ray equipment has been further refined with a specific focus on radiation safety. However, minimising radiation requires the active interaction of the operator with the machine. The paper by Ge et al in this issue of EuroIntervention6 contributes to the still scarce literature on radiation exposure and active radiation reduction in CTO PCI.

This is for the benefit of the patient, and also for the sake of the operator and the cath lab staff7. The authors report on a modified low-dose protocol based on modified filters and a reduced frame rate for cineangiography. They observed no loss of procedural success or safety during their procedures. They do not compare this to a previous time period but put it into perspective with recently published data from other CTO registries. They also present an experimental model in which they showed the positive impact of this protocol on radiation dose. They varied projection angles and recorded operator exposure and compared this to a standard protocol without filters and higher cine frame rates.

The observed reduction in radiation dose could have been even higher, if the operators had modified the fluoroscopy rate as well. It should be noted that of course radiation during cineangiography is the main contributor to the total radiation exposure but, given the trend to use fluoroscopy storage wherever feasible and reduce cineangiography to a minimum, the contribution of fluoroscopy frame rates becomes more relevant. A randomised study on the radiation saving effect of a fluoroscopy rate of 7.5 versus standard rates of 15/s showed a significant radiation reduction. Again that study did not use the whole potential of radiation reduction as they used cineangiographic frame rates of 15/s8. The human eye can hardly discriminate between a 15 or 7.5/s frame rate and, if the equipment allows the modification, we can even work comfortably with 6 pulses/s for fluoroscopy, with no negative impact on the success rate9. We may increase the cineangiographic rate to 15/s for detailed assessment of the collateral circulation, but then should actively reduce it again and prefer fluoro over cine documentation.

Ge et al compare their study results with a few published registry observations, but what is missing as one of the major determinants of radiation exposure is the body weight or body mass index (BMI). This value is required to compare studies in different populations. In the USA, and also in Europe, the weight and BMI are considerably higher. In the present study the BMI was 25.9, in our study it was 28.8 at 88 kg9, and in the recent OPEN-CTO registry from the USA the air kerma (AK) of 2.5 Gy was as low as in Ge’s study, but at a BMI of 30.510.

These comparisons underscore the potential of further optimising the radiation reduction measures in our cath labs beyond that which was demonstrated in the current study. The management of radiation must be an integral part of a CTO procedure and the general ALARA (as low as reasonably achievable) rule of radiography needs to be followed. While in the USA an excess of radiation may even carry legal consequences, this is not the case in most other countries. However, it is the operator’s responsibility to minimise damage to the patient and to do what is possible with the highly developed X-ray systems we have available.

Conflict of interest statement

The author has no conflicts of interest to declare.


References

Volume 14 Number 5
Aug 3, 2018
Volume 14 Number 5
View full issue


Key metrics

On the same subject

10.4244/EIJV15I2A27 Jun 20, 2019
Chronic total occlusion percutaneous coronary intervention: the road ahead
Brilakis E et al
free

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
Trending articles
337.88

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
283.98

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
226.03

State-of-the-Art Review

10.4244/EIJ-D-21-00426 Dec 3, 2021
Myocardial infarction with non-obstructive coronary artery disease
Lindahl B et al
free
209.5

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.4

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
150.28

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
103.48

Expert consensus

10.4244/EIJ-E-22-00018 Dec 4, 2023
Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations
Lunardi M et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved